Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin

J Invest Dermatol. 2011 Sep;131(9):1947-50. doi: 10.1038/jid.2011.124. Epub 2011 Jun 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Cytokines / metabolism*
  • Dermatologic Agents / administration & dosage*
  • Female
  • Humans
  • Infliximab
  • Netherton Syndrome / drug therapy*
  • Netherton Syndrome / metabolism*
  • Netherton Syndrome / pathology
  • Skin / drug effects
  • Skin / metabolism
  • Skin / pathology
  • Thymic Stromal Lymphopoietin

Substances

  • Antibodies, Monoclonal
  • Cytokines
  • Dermatologic Agents
  • Infliximab
  • Thymic Stromal Lymphopoietin